Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
Cash from Financing Activities
Takeda Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥302.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥123.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥60.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Eisai Co Ltd
TSE:4523
|
Cash from Financing Activities
-¥39.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
10%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥139.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-20%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
¥478.6B
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Takeda Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-302.8B
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -302.8B JPY.
What is Takeda Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
29%
Over the last year, the Cash from Financing Activities growth was 68%. The average annual Cash from Financing Activities growth rates for Takeda Pharmaceutical Co Ltd have been 29% over the past three years .